These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adverse cutaneous drug eruptions and HIV: a clinician's global perspective. Todd G Dermatol Clin; 2006 Oct; 24(4):459-72, vi. PubMed ID: 17010776 [TBL] [Abstract][Full Text] [Related]
5. Bayesian differential diagnosis of a cutaneous reaction associated with the administration of sulfonamides. Ghajar BM; Lanctôt KL; Shear NH; Naranjo CA Semin Dermatol; 1989 Sep; 8(3):213-8. PubMed ID: 2534885 [No Abstract] [Full Text] [Related]
6. Fixed skin eruptions may indicate drug sensitivity. Taub SJ Eye Ear Nose Throat Mon; 1973 Oct; 52(10):374. PubMed ID: 4270613 [No Abstract] [Full Text] [Related]
7. A guide to understanding adverse drug reactions. Seal R Community Nurse; 2000 Apr; 6(3):53-6. PubMed ID: 12778510 [No Abstract] [Full Text] [Related]
9. New advances in severe adverse drug reactions. Revuz J Dermatol Clin; 2001 Oct; 19(4):697-709, ix. PubMed ID: 11705355 [TBL] [Abstract][Full Text] [Related]
10. Inpatient adverse cutaneous drug eruptions and eosinophilia. Romagosa R; Kapoor S; Sanders J; Berman B Arch Dermatol; 2001 Apr; 137(4):511-2. PubMed ID: 11295947 [No Abstract] [Full Text] [Related]
11. Severe cutaneous reaction following measles immunization. Inamadar AC; Patil SS; Palit A Int J Dermatol; 2009 Aug; 48(8):873-4. PubMed ID: 19659866 [No Abstract] [Full Text] [Related]
12. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Lammintausta K; Kortekangas-Savolainen O Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795 [TBL] [Abstract][Full Text] [Related]
14. The Janus faces of allopurinol-allopurinol hypersensitivity syndrome. Tausche AK; Aringer M; Schroeder HE; Bornstein SR; Wunderlich C; Wozel G Am J Med; 2008 Mar; 121(3):e3-4. PubMed ID: 18328291 [No Abstract] [Full Text] [Related]
15. [Is it possible to confirm a suspected phenacetine allergy by an aimed skin test?]. Nasemann T Landarzt; 1968 Jan; 44(2):96. PubMed ID: 4238214 [No Abstract] [Full Text] [Related]
16. Allergological approach to drug hypersensitivity reactions. Przybilla B; Aberer W; Bircher AJ; Brehler R; Brockow K; Dickel H; Fuchs T; Hertl M; Mockenhaupt M; Pfaar O; Ring J; Sachs B; Vieluf D; Wedi B; Worm M; Zuberbier T; Merk HF J Dtsch Dermatol Ges; 2008 Mar; 6(3):240-3. PubMed ID: 18205837 [No Abstract] [Full Text] [Related]
18. [Neither skin tests nor challenge tests are sufficient to provide formal diagnosis of drug allergy or sensitisation. A discussion of the article "Two medicines of similar imputability in dermal adverse drug reactions (two cases): the limitations of epicutaneous testing?" by P. Dellestable et al]. Augey F; Guneraa-Saad N; Bérard F; Nicolas JF Ann Dermatol Venereol; 2008 Dec; 135(12):867-8. PubMed ID: 19084703 [No Abstract] [Full Text] [Related]
19. [Clinical and histological features of cutaneous drug reactions]. Collet E; Touraud JP; Justrabo E; Ponnelle T; Sgro C; Lambert D Therapie; 2002; 57(3):254-6. PubMed ID: 12422536 [TBL] [Abstract][Full Text] [Related]
20. Fixed drug eruption: state of the art. Ozkaya E J Dtsch Dermatol Ges; 2008 Mar; 6(3):181-8. PubMed ID: 18076661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]